NCT01360606View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy (SBRT) for Liver Mets

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 23, 2012

Primary Completion Date

July 25, 2018

Study Completion Date

February 4, 2021

Conditions
Liver Metastases
Interventions
RADIATION

Stereotactic Body Radiation Therapy

"SBRT:~Patients will receive one of the following radiation regimens:~* 50 Gy in 5 fractions (10 Gy/fx) delivered over a 2-week period.~* 60 Gy in 5 fractions (12 Gy/fx) delivered over a 2-week period.~* 75 Gy in 5 fractions (15 Gy/fx) delivered over a 2-week period."

Trial Locations (1)

15232

UPMC Hillman Cancer Center - Radiation Oncology, Pittsburgh

All Listed Sponsors
lead

Susannah Ellsworth

OTHER

NCT01360606 - Stereotactic Body Radiation Therapy (SBRT) for Liver Mets | Biotech Hunter | Biotech Hunter